Sign Up Today and Learn More About Sano Stock
Invest in or calculate the value of your shares in Sano or other pre-IPO companies through EquityZen's platform.
Sano Stock
Sano is developing a low cost, Point of Care diagnostic platform to early detect and intervene in at least 6 different diseases.
About Sano Stock
Headquarters
Wellesley, MA, US
Total Funding
50K
Industries
Sano is developing a low cost, Point of Care diagnostic platform to early detect and intervene in at least 6 different diseases affecting human and vet populations. Their first focus is human chronic wounds, such as diabetic foot ulcers and venous​​ leg ulcers, personalizing treatment to promote faster healing and avoid over $3B in treatment costs from trial and error and prolonged chronicity. They have tested their proprietary chemistry, have prototypes designed, and soon will start clinical trials and submit for regulatory clearance. "Low Cost" means that they not only anticipate faster adoption in the developed world, but also that their solution is truly a global solution, not one reserved for wealthy nations alone as obesity, diabetes, and aging population are trends affecting nearly every nation and sharply increase the incidence of chronic wounds.
Sano Press Mentions
Stay in the know about the latest news on Sano
A Little-Known Technology That Fitbit and Apple are Exploring Could Be The Answer To Healthy Eating and Peak Performance
Business Insider • Feb 03, 2018
Fitbit Has Invested $6 Million in Glucose-Monitoring Startup Sano
The Verge • Jan 05, 2018
Sano Management
Leadership team at Sano
Chief Scientific Officer
Dan Kerschensteiner
President
Paul Hayre
Join now and verify your accreditation status to gain access to:
- Sano current valuation
- Sano stock price
- Available deals in Sano and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Sano stock?
Accredited investors can buy pre-IPO stock in companies like Sano through EquityZen funds. These investments are made available by existing Sano shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Sano stock?
Shareholders can sell their Sano stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
